FRAS 4 Evolvo

It is now available for medical doctors and other health professionals, the new FRAS 4 Evolvo, an integrated system that allows one to globally assess oxidative stress, by means of two tests, d-ROMs test and BAP test.

The d-ROMs test allows one to determine the blood concentration of reactive oxygen metabolites (ROMs) and, particularly, that of hydroperoxides, which are markers and amplifiers of free radicals-induced oxidative damage.

The BAP test allows one to determine the effectiveness of plasma antioxidant barrier, as iron-reducing activity.

By means of these tests, it is now possible to formulate a more precise and reliable laboratory diagnosis of oxidative stress, where the two distinct and opposite components, either pro- or anti-oxidant can be assessed in a distinguished manner. In other words, it is now possible to establish in "real time" whether oxidative stress depends on an increased production of free radicals and/or a decreased efficacy of inactivating them. Therefore, antioxidant therapy monitoring also can now lean on more solid bases, thus going out its actual "empirical phase".

Order

FRAS 4 Evolvo is the latest evolution of the FRAS instrument. Its most innovative aspects are:

  • new body stylized in ABS (more resistent than the one in BaydurTM)
  • totally ridesigned electronics with last generation components able to guarantee the maximum repeatability and accuracy
  • LED lamp at 505 nm with high efficiency and almost unlimited life span
  • thermic printer with static printhead (estimated life span 10 times greater than the previous printhead)
  • printing mechanism with easy paper roll change
  • possibility to insert graphic logo and customized header via PC
  • possibility to update the softward and add new tests via PC
  • possibility to take the d-ROMs and BAP test with a single blood collection from the fingertip with a single microvette.
  • producted entirely in Italy

Everyone should undergo the oxidative stress assessment, even if they are healthy, and even more if one is continuously exposed to pro-oxidant factors (i. e. incorrect life-style, pollutants in work environment, etc.) or it is suffering from chronic degenerative diseases (i. e. diabetes, atherosclerosis, dementia, Parkinson's disease, Chron's disease, Down's disease, rheumatoid arthritis, cancers, etc.) or, finally, if one undergoes some treatments (i.e. dialysis, by-pass, grafting, pill, radiotherapy, chemotherapy, etc.).

Only by means of this global assessment it will be possible to optimize specific therapies and to monitor the real effectiveness of antioxidant formulas, where often their intake is not accompanied by a preliminary test able to demonstrate its necessity.

Our brands